• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vaishali Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71078.0
  • ISIN : INE972X01022
12.69 0 (-0.16%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    12.50

  • Today’s High

    12.95

  • Open

    12.95

  • Perv Close

    12.71

  • 52W Low

    10.30

  • 52W High

    24.91

Key Indicators

  • P/E(TTM)

    158.63

  • Mar.Cap (₹Cr.)

    136.03

  • Div & Yield %

    0.00

  • Book Value(₹)

    5.62

  • Debt-Equity Ratio

    -0.16

  • AGM Date

    30-May-2025

  • EPS

    0.08

  • P/E Ratio

    158.63

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    136.03

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.44

  • BV (₹)

    5.60

  • Sales( ₹ in Cr.)

    99.03

  • NP (in Cr.)

    0.82

  • NP Var(%)

    14.0

  • Div%

    0.0

  • CPS (₹)

    0.10

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    136.03

  • 52 Week High

    24.91

  • 52 Week Low

    10.30

  • Price BSE

    0.0

  • Price NSE

    13.00

  • Market Capital( in Cr.)

    136.03

  • P/C Ratio

    106.90

  • P/E Ratio

    170.50

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 86.28 69.66 75.82 53.77 60.09 75.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 86.28 69.66 75.82 53.77 60.09 75.09
Other Income 2.03 2.23 1.79 1.81 2.17 1.98
Stock Adjustments -2.67 2.42 0.04 -0.29 -0.10 -0.89
Total Income 85.64 74.31 77.65 55.29 62.16 76.18
EXPENDITURE :            
Raw Materials 71.75 57.10 63.54 45.86 50.99 67.78
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 1.40 1.30 1.36 1.19 1.27 2.13
Other Manufacturing Expenses 0.02 0.02 0.02 0.02 0.02 0.03
Selling and Administration Expenses 3.44 4.28 4.06 1.94 2.62 2.15
Miscellaneous Expenses 5.33 0.00 0.00 1.82 4.19 0.04
Employee Benefit Expenses 1.40 1.30 1.36 1.19 1.27 2.13
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 81.95 62.71 68.97 50.83 59.09 72.13
Operating Profit 3.70 11.61 8.67 4.46 3.08 4.06
Interest 2.27 2.26 2.49 2.63 2.56 2.66
Gross Profit 1.43 9.35 6.18 1.83 0.52 1.40
Depreciation 0.51 0.50 0.46 0.43 0.44 0.27
Profit Before Tax 0.92 8.85 5.72 1.40 0.08 1.13
Current Tax 0.25 2.24 1.72 0.38 0.06 0.45
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.04 0.00 -0.02 -0.02 -0.01 -0.03
Reported Net Profit 0.72 6.60 4.02 1.05 0.03 0.71
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.72 6.60 4.02 1.05 0.03 0.71
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 14.19 7.59 3.57 2.52 2.49 1.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 14.91 14.19 7.59 3.57 2.52 2.49
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.67 6.26 3.82 0.99 0.03 1.08
Earnings Per Share(Adj)-Unit Curr 0.67 6.26 3.82 0.99 0.03 0.68
Book Value 39.97 38.43 24.99 21.26 20.27 32.47
Book Value(Adj)-Unit Curr 39.97 38.43 24.99 21.26 20.27 20.30

Shareholding Pattern

  • Promoter Group

    26.32%

  • Public Share Holding

    73.68%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 50 0.00 50 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 28,215,240 26.32 28,215,240 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 28,215,290 26.32 28,215,290 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 5,634,918 5.26 5,634,918 46
Clearing Members 196,677 0.18 196,677 11
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,005,083 0.94 1,005,083 168
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,206,533 2.06 2,206,533 330
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 34,686,045 32.36 34,686,045 68
Individuals holding nominal share capital up to Rs. 1 lakh 35,242,854 32.88 35,242,854 28,240
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 78,976,840 73.68 78,976,840 28,864
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 107,192,130 100.00 107,192,130 28,874

Company Background

Vaishali Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vaishali Pharma Ltd
  • BSE Code : 71078.0
  • ISIN : INE972X01022

  • Incorporation Year

    2008

  • Registered Office

    706 to 709 7th Floor Aravali
    Business Centre Borivali(W), Mumbai,
    Maharashtra-400092

  • Telephone

    91-22-28928833

  • FAX

    91-22-28928833

  • Chairman

    Atul Vasani

  • Managing Director

    Atul Vasani

  • Company Secretary

    Vishwa Mekhia

  • Auditor

    Raman S Shah & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Vaishali Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vaishali Pharma 12.69 88.31 86.28 158.63 5.71
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92